Study directory

Mental health studies with practical context.

Public study records, presented in a clearer and more patient-friendly format for mental health research discovery.

Back to overview

10592studies shown

Showing 7,885-7,896 of 10,592

Drug study icon

CompletedNCT02884908

Pharmacogenetic Treatment With Anti-Glutaminergic Agents for Comorbid PTSD & AUD

This summary needs review. Please check the official study record and contact the research team for details.

In United States

PTSD, AddictionDrugFrom 18 Years to 65 Years

Countries: United States
Sponsor: University of Maryland, Baltimore
Condition: PTSD, Addiction

Drug study icon

WithdrawnNCT01591291

Pharmacogenetic Treatments for Alcoholism

This summary needs review. Please check the official study record and contact the research team for details.

In United States

AddictionDrugFrom 18 Years to 65 Years

Countries: United States
Sponsor: University of Virginia
Condition: Addiction

Behavioral study icon

CompletedNCT01953432

Pharmacogenetic study of Doxazosin for Treatment of Cocaine Abuse

This summary needs review. Please check the official study record and contact the research team for details.

In United States

Mental healthBehavioralFrom 18 Years to 64 Years

Countries: United States
Sponsor: VA Office of Research and Development
Condition: Mental health

Drug study icon

CompletedNCT00678730

Pharmacogenetics of Cannabinoid Response

This summary needs review. Please check the official study record and contact the research team for details.

In United States

SchizophreniaDrugFrom 18 Years to 55 Years

Countries: United States
Sponsor: Yale University
Condition: Schizophrenia

Drug study icon

CompletedNCT03226223

Pharmacogenetics of Naltrexone for Stimulant Abuse

This summary needs review. Please check the official study record and contact the research team for details.

In United States

AddictionDrugFrom 21 Years to 50 Years

Countries: United States
Sponsor: New York State Psychiatric Institute
Condition: Addiction

Drug study icon

CompletedNCT01314001

Pharmacogenetics of Nicotine Addiction Treatment

This summary needs review. Please check the official study record and contact the research team for details.

In United States

AddictionDrugFrom 18 Years to 65 Years

Countries: United States, Canada
Sponsor: University of Pennsylvania
Condition: Addiction

Drug study icon

CompletedNCT00507728

Pharmacogenetics, Emotional Reactivity and Smoking

This summary needs review. Please check the official study record and contact the research team for details.

In United States

AddictionDrugFrom 18 Years to 65 Years

Countries: United States
Sponsor: M.D. Anderson Cancer Center
Condition: Addiction

Biological study icon

CompletedNCT04500301

Pharmacogenomic Testing to Personalize Supportive Oncology

This summary needs review. Please check the official study record and contact the research team for details.

In United States

DepressionOtherOver 18 Years

Countries: United States
Sponsor: Wake Forest University Health Sciences
Condition: Depression

Behavioral study icon

CompletedNCT03674138

Pharmacogenomic-Guided Antidepressant Drug Prescribing in Cancer Patients

This study exists to learn from real-world information that can show how a therapy or guided support program fits into care. Researchers are trying to understand what a therapy or guided support program could change in day-to-day care and decision-making.

In United States

Depression, AnxietyBehavioralOver 18 Years

Countries: United States
Sponsor: H. Lee Moffitt Cancer Center and Research Institute
Condition: Depression, Anxiety

Drug study icon

CompletedNCT03818191

Pharmacogenomics and Pharmacometabolomics of Acamprosate Treatment Outcome

This summary needs review. Please check the official study record and contact the research team for details.

In United States

AddictionDrugFrom 18 Years to 85 Years

Countries: United States
Sponsor: Mayo Clinic
Condition: Addiction

Other study type icon

TerminatedNCT03730870

Pharmacogenomics for Improving Pediatric ADHD Treatment

This study exists to compare options and see whether a medication treatment offers something meaningfully different. Researchers are trying to understand whether a medication treatment can improve attention, thinking, or day-to-day functioning.

In United States

ADHDDiagnostic TestFrom 6 Years to 18 Years

Countries: United States
Sponsor: Clinical and Translational Genome Research Institute, Inc.
Condition: ADHD

Drug study icon

CompletedNCT00516932

Pharmacogenomics of Antidepressant Response in Children and Adolescents

This summary needs review. Please check the official study record and contact the research team for details.

In United States

Suicidality, OCD, ...OtherFrom 7 Years to 17 Years

Countries: United States
Sponsor: Duke University
Condition: Suicidality, OCD, ...

Data coverage

Public registry coverage is progressing

HopeStage gathers information about mental health clinical trials from the public registries we currently index. We are progressively improving registry coverage, but this does not mean that every study in the world is already included.